Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis

Published:2021-01-04 Issue:6 Volume:116 Page:1514-1520
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Antoniou Tony¹²³⁴,Martins Diana¹,Campbell Tonya²,Tadrous Mina²⁵⁶,Munro Charlotte⁷,Leece Pamela⁸,Mamdani Muhammad¹²⁶⁹¹⁰,Juurlink David N.²⁴⁶¹⁰¹¹,Gomes Tara¹²⁶⁹^ORCID

Affiliation:

1. Li Ka Shing Knowledge Institute of St. Michael's Hospital Toronto Ontario Canada

2. ICES Toronto Ontario Canada

3. Department of Family and Community Medicine, Unity Health Toronto Ontario Canada

4. Department of Pediatrics University of Toronto Toronto Ontario Canada

5. Women's College Hospital Toronto Ontario Canada

6. Family and Community Medicine University of Toronto Toronto Ontario Canada

7. Ontario Drug Policy Research Network Lived Experience Advisory Group Toronto Ontario Canada

8. Public Health Ontario Toronto Ontario Canada

9. Institute of Health Policy, Management, and Evaluation University of Toronto Toronto Ontario Canada

10. Department of Medicine University of Toronto Toronto Ontario Canada

11. The Sunnybrook Research Institute Toronto Canada

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15324

Reference38 articles.

1. Centers for Disease Control and Prevention.Provisional Drug Overdose Death Counts. Available at:https://www.cdc.gov/nchs/nvss/vsrr/drug‐overdose‐data.htm(accessed 20 January 2020).

2. Government of Canada.Apparent Opioid‐Related Deaths: Surveillance of Opioid‐related Harms in Canada. Available at:https://health‐infobase.canada.ca/substance‐related‐harms/opioids/graphs?index=328(accessed 17 August 2020).

3. Understanding the Implications of a Shifting Opioid Landscape in Ontario

4. Measuring the Burden of Opioid-related Mortality in Ontario, Canada

5. Ontario Agency for Health Protection and Promotion (Public Health Ontario) Office of the Chief Coroner Ontario Forensic Pathology Service Ontario Drug Policy Research Network.Opioid mortality surveillance report: analysis of opioid‐related deaths in Ontario July 2017–June 2018. Toronto Ontario: Public Health Ontario;2019.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An economic evaluation of community pharmacy–dispensed naloxone in Canada;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2024-02-13

3. ‘I don't chase drugs as much anymore, and I'm not dead’: Client reported outcomes associated with safer opioid supply programs in Ontario, Canada;Drug and Alcohol Review;2023-09-18

4. Characterizing Methamphetamine Use Among People Who Use Opioids: A Systematic Review;International Journal of Mental Health and Addiction;2023-09-06

5. Evidence of the Impact of Harm Minimization Programs;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023